🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yazeed Sawalha

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

ORCID: 0000-0001-6355-3671

Also affiliated with The Ohio State University Wexner Medical Center, The Ohio State University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Outcomes of patients with diffuse large B-cell and high-grade B-cell lymphomas with synchronous CNS and systemic involvement at diagnosis treated with high-dose methotrexate and R-CHOP: a single-center retrospective study”.

Outcomes of patients with diffuse large B-cell and high-grade B-cell lymphomas with synchronous CNS and systemic involvement at diagnosis treated with high-dose methotrexate and R-CHOP: a single-center retrospective study

Therapeutic Advances in Hematology(2022)10.1177/20406207221112900
N/A
0.345DataRank · unranked
9 citations

Ying Huang, Emily Dotson, David A. Bond, John Reneau, Narendranath Epperla +7 more

Older patients with mantle cell lymphoma (MCL): Practice patterns and predictors of survival in the rituximab era.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e20064
N/A
0DataRank · unranked
0 citations

Jeffrey M. Switchenko, Subir Goyal, Veronika Bachanová, James N. Gerson, Stefan K. Barta +15 more

Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy

Blood Advances(2021)10.1182/bloodadvances.2021004765
N/A
0DataRank · unranked
41 citations

Jeffrey M. Switchenko, Diego Villa, Kami J. Maddocks, Michael C. Churnetski, Alina S. Gerrie +30 more

Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma

Blood Advances(2022)10.1182/bloodadvances.2022009225
N/A
0DataRank · unranked
11 citations

Jeffrey M. Switchenko, Veronika Bachanová, James N. Gerson, Stefan K. Barta, Max J. Gordon +30 more

A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma

Blood Advances(2023)10.1182/bloodadvances.2022008916
N/A
0DataRank · unranked
29 citations

Subir Goyal, Jeffrey M. Switchenko, Jason T. Romancik, Manali Kamdar, Irl Brian Greenwell +17 more